PFIZER

Cytisine, a plant-based drug discovered by the Soviet Union more than 40 years ago, may be the key to lowering cigarette smoking rates in the developing world.

Combination of Afinitor® and Aromasin can buy you more time before the breast cancer situation worsens.

Scientists have found a way to prevent HIV from damaging the immune system and say their discovery may offer a new approach to developing a vaccine against AIDS.

Despite the FDA advisory panel's backing, RBC Capital Markets does not believe Johnson & Johnson's (NYSE: JNJ) Xarelto is well positioned to receive marketing approval on Nov. 5.

Stock index futures pointed to a lower open on Thursday as data showed a weaker labor market ahead of a speech by U.S. President Barack Obama detailing his plan for jobs growth.

AstraZeneca Plc's key cholesterol drug Crestor failed to beat Pfizer Inc's Lipitor in a head-to-head clinical study, limiting any protection the British company will get as its U.S. rival faces competition from cheap generic copies.

IBM, the No. 2 computer services company, has snapped up technology players in Canada and the UK -- demonstrating an appetite for new technologies but also for tax advantages.

Pfizer Inc reached a settlement with Dr. Reddy's Laboratories , an Indian drugmaker that has been fighting in court to launch cheaper generic forms of Pfizer's blockbuster cholesterol fighter, the companies said on Wednesday .

Roche expects a new generation of drugs targeted at specific groups of patients to make up half its portfolio in 10 years, a shift that is pushing the boundaries of modern medicine.

New York City-based Pfizer Inc. gained FDA approval for their drug Xalkori, the first new medicine in several years for deadly, advanced lung cancer, according to new research.

Thousands of Washington lobbyists are scrambling to influence the work of a congressional super committee given the job of identifying up to $1.5 trillion in deficit reductions, with many worried about how to gain access to its 12 members.

An experimental anti-clotting drug from Bristol-Myers Squibb and Pfizer saved more lives than standard treatment warfarin in a major study, giving it an edge over rivals in an emerging multibillion-dollar market.

The Food and Drug Administration (FDA) has given the approval for a new Pfizer drug which will be useful for treating certain group of lung cancer patients having specific genetic mutation.

Xalkori is a Pfizer drug, and it works by targeting specific genes found certain patients. This gene is called the abnormal anaplastic lymphoma kinase (ALK) gene and is present in about 1 to 7 percent of non-small cell lung cancer patients.

Despite being third to market, a new bloodthinner from Bristol-Myers Squibb and Pfizer may become the biggest seller in an emerging multibillion-dollar class of drugs for preventing strokes in heart patients.

Despite being third to market, a new bloodthinner from Bristol-Myers Squibb and Pfizer may become the biggest seller in an emerging multibillion-dollar class of drugs for preventing strokes in heart patients.

Kodak's patent auction can benefit shareholders as well as the U.S.

Pfizer Inc said on Monday it won a patent infringement case against the U.S. unit of Teva Pharmaceutical Industries Ltd, preventing Teva from launching a generic version of Pfizer's erectile dysfunction drug Viagra until October 2019.

Recent industry buzz on Pfizer's alleged strategy to sell its cholesterol reducer-blockbuster drug, Lipitor as an over-the-counter pill, reinforces debate on the safe compliance of prescription drugs when sold as OTC's.

Pfizer Inc is interested in selling a non-prescription version of its Lipitor cholesterol drug after it loses U.S. patent protection, but would likely face a battle with regulators because of safety concerns, the Wall Street Journal reported on Wednesday.

The S&P 500 turned negative for the year on Tuesday as the wrangling over the U.S. debt ceiling faded and investors turned their attention to the stalling economy.